Articles

Amylyx (AMLX) Stock Spikes 13% as FDA Resumes Discussion of ALS Drug

A new wrinkle in the story of Amylyx Pharmaceuticals' ongoing battle against ALS bodes well for patients, and for AMLX stock holders. More 

MICS, AERC: 5 Top Short Squeeze Stocks to Watch

With a new week comes all of the latest short squeeze stocks that investors are going to want to keep an eye on and we've got a list to help! More 

Avoid Wishful Thinking and Steer Clear of ContextLogic Stock

Selling cheap products hasn't been a profitable business model for ContextLogic, so it's logical to stay away from WISH stock altogether. More 

Weekly Upgrades and Downgrades

During these busy times, it pays to stay on top of the latest profit opportunities. And today’s blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company’s fundamental health, I decided to revise my Portfolio Grader recommendations for 57 big… More 

Meta Gets Ready to Shelve Novi Crypto Wallet After Pilot Fails to Catch On

Meta is shutting the doors on its Novi cryptocurrency wallet, closing a chapter in the company's aggressive Web 3.0 push. More 

Why Are Oil Stocks Down Today?

Oil stocks and oil prices are declining meaningfully today as fears of a recession mount and Russia announces a new oil discovery. More 

6 Recession-Proof Stocks to Buy as the Market Boom Ends

These stocks pay dividends, have low payout ratios, low P/E multiples, and good growth. These six stocks are in industries and fields that make them recession-proof stocks, especially given their dividend yields and low multiples. More